Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases-Reference-Cited by-同舟云学术

Adverse drug reaction risks obtained from meta-analyses and pharmacovigilance disproportionality analyses are correlated in most cases

Published:2021-06 Issue: Volume:134 Page:14-21
ISSN:0895-4356
Container-title:Journal of Clinical Epidemiology
language:en
Short-container-title:Journal of Clinical Epidemiology

Author:

Khouri Charles^ORCID,Petit Camille,Tod Michel,Lepelley Marion,Revol Bruno^ORCID,Roustit Matthieu,Cracowski Jean-Luc

Funder

United Therapeutics Corporation

Publisher

Elsevier BV

Subject

Epidemiology

Reference44 articles.

1. Guideline on the use of Statistical Signal Detection Methods in the EudraVigilance Data Analysis System - Doc. Ref. EMEA/106464/ 2006 rev. 1. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/11/WC500011434.pdf n.d.

2. Defining “signal” and its subtypes in pharmacovigilance based on a systematic review of previous definitions;Hauben;Drug Saf,2009

3. Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems;Raschi;Nutr Metab Cardiovasc Dis NMCD,2018

4. An empirical approach to explore the relationship between measures of disproportionate reporting and relative risks from analytical studies;Maciá-Martínez;Drug Saf,2016

5. Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase;Mahé;Br J Clin Pharmacol,2018

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse cardiovascular events in rheumatoid arthritis patients treated with JAK inhibitors: An analysis of postmarketing spontaneous safety reports;Seminars in Arthritis and Rheumatism;2024-08

2. Comparing the adverse effects of ketamine and esketamine between genders using FAERS data;Frontiers in Pharmacology;2024-07-12

3. Meta-analyzing Results From Disproportionality Analysis of Individual Case Safety Reports;Journal of Clinical Psychopharmacology;2024-06-21

4. Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study;Expert Opinion on Drug Safety;2024-05-16

5. Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database;Drug Safety;2024-05-09